Extracellular matrix signatures of human mammary carcinoma identify novel metastasis promoters.

Data from Massive, MSV000078535. MDAMB23 experiment: D101003_MDAMB231_1_OGE, file: D101003_MDAMB231_1_OGE02_rafkt_ft8_cc_01.mzml. Published as part of Elife. 2014 Mar 11;3:e01308 . From the Abstract: {{i}} In this study, we use proteomics to investigate the ECM of human mammary carcinoma xenografts and show that primary tumors of differing metastatic potential differ in ECM composition. Both tumor cells and stromal cells contribute to the tumor matrix and tumors of differing metastatic ability differ in both tumor- and stroma-derived ECM components. {{/i}}